The Europe rat model market was worth $XX thousand in the year 2018. It is estimated to grow at a CAGR of 7.67% for the forecast year 2019-2027 and generate $XX thousand by the year 2027. The rat models are widely used in experimental research by scientists and by the big biotechnological and pharmaceutical companies due to the availability of enormous sample size and the similarity in the metabolic physiology of rat models to that of the humans
EUROPE RAT MODEL MARKET FORECAST 2019- 2027
Europe Rat Model Market by Rat Type (Inbred, Genetically Engineered Rats, Surgically Modified Rats, Hybrid, Outbred, Immune-deficien)Â by Application (Diabetes, Toxicology, Oncology, Immunology & Inflammation, Other Application) by Component(Technology, Services, Rat Care Products) by Geography.
The Europe rat model market was worth $XX thousand in the year 2018. It is estimated to grow at a CAGR of 7.67% for the forecast year 2019-2027 and generate $XX thousand by the year 2027. The rat models are widely used in experimental research by scientists and by the big biotechnological and pharmaceutical companies due to the availability of enormous sample size and the similarity in the metabolic physiology of rat models to that of the humans. Ongoing innovations in genome-editing techniques will be accounting for increased demand among the researcher for the use of the rat model system.
The regions analyzed for the European market are the United Kingdom, France, Germany, Spain, Italy and the Rest of Europe (RoE). Germany is currently the leader in the European rat model market because of the presence of lucrative R&D schemes in the market and the fact that a large number of commercial investors are investing in the research area. The global rat model market by toxicology application holds the leading market position in the forecasted period. Also, the global rat model market by oncology application holds the fastest growing market position in the forecasted period.
The major players in the European rat model market are Oncodesign S.A., Janvier Labs, Transviragen Inc., Charles River Laboratories Inc., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Taconic Biosciences, Envigo, Clea Japan, Laboratory Corporation of America Holdings, Cyagen Biosciences Inc., Hera Biolabs Inc., Vivo Biotech Ltd., Genoway S.A., Biomere and Transposagen Biopharmaceuticals Inc.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
- ONCOLOGY IS THE FASTEST GROWING APPLICATION
- RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- ENHANCEMENT IN GENOME EDITING
- GROWING AVAILABILITY OF TRANSGENIC RAT
- SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
- MARKET RESTRAINTS
- PRACTICE OF ANIMALS IN RESEARCH IS CONSIDERED UNETHICAL
- FLUCTUATING RULES AND REGULATION ON ANIMAL TESTING
- USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
- IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
- MARKET OPPORTUNITIES
- PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
- ESCALATION IN MONOCLONAL ANTIBODY CREATION
- MARKET CHALLENGES
- HIGHLY EXPENSIVE RAT MODEL
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- INTENSITY OF COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
- REGULATORY FRAMEWORK
- KEY BUYING CRITERIA
- HIGH ACCURACY
- HIGH EFFICACY
- QUALITY OF OPERATING PROCEDURE
- PRICE
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- BIOMERE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- CHARLES RIVER LABORATORIES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CLEA JAPAN
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CYAGEN BIOSCIENCES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ENVIGO
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- GENOWAY S.A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HERA BIOLABS INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- JANVIER LABS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- ONCODESIGN S.A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TACONIC BIOSCIENCES
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSPOSAGEN BIOPHARMACEUTICALS INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSVIRAGEN INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- VIVO BIOTECH LTD.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BIOMERE
TABLE LIST
TABLE 1Â Â Â Â Â Â Â EUROPE RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2Â Â Â Â Â Â Â BENEFITS OF RAT TRANSGENIC
TABLE 3Â Â Â Â Â Â Â EUROPE RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4Â Â Â Â Â Â Â EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5Â Â Â Â Â Â Â EUROPE INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6Â Â Â Â Â Â Â EUROPE GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7Â Â Â Â Â Â Â EUROPE SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8Â Â Â Â Â Â Â EUROPE HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9Â Â Â Â Â Â Â EUROPE OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10Â Â Â Â Â EUROPE IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11Â Â Â Â Â EUROPE RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12Â Â Â Â Â EUROPE DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13Â Â Â Â Â EUROPE TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14Â Â Â Â Â EUROPE ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15Â Â Â Â Â EUROPE IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16Â Â Â Â Â EUROPE OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17Â Â Â Â Â EUROPE RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18Â Â Â Â Â EUROPE TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19Â Â Â Â Â EUROPE NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20Â Â Â Â Â EUROPE MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21Â Â Â Â Â EUROPE EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22Â Â Â Â Â EUROPE OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23Â Â Â Â Â EUROPE SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24Â Â Â Â Â EUROPE RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25Â Â Â Â Â EUROPE FEED MARKET 2019-2027 ($ MILLION)
TABLE 26Â Â Â Â Â POPULAR FOOD FOR RATS
TABLE 27Â Â Â Â Â EUROPE BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28Â Â Â Â Â EUROPE CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29Â Â Â Â Â EUROPE OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30Â Â Â Â Â EUROPE RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31Â Â Â Â Â RAT MODEL COMPANY POSITION ANALYSIS
FIGURES LISTÂ Â Â Â Â Â
FIGURE 1Â Â Â Â Â EUROPE RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2Â Â Â Â Â EUROPE RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3Â Â Â Â Â EUROPE RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4Â Â Â Â Â EUROPE RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5Â Â Â Â Â EUROPE RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6Â Â Â Â Â EUROPE RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7Â Â Â Â Â EUROPE RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8Â Â Â Â Â EUROPE RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9Â Â Â Â Â EUROPE RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10Â Â PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 AND 2040
FIGURE 11Â Â EUROPE RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12Â Â EUROPE RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13Â Â EUROPE RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14Â Â EUROPE RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15Â Â EUROPE RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16Â Â EUROPE RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17Â Â EUROPE RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18Â Â EUROPE RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19Â Â EUROPE RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20Â Â EUROPE RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21Â Â EUROPE RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22Â Â EUROPE RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23Â Â EUROPE RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24Â Â EUROPE RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25Â Â EUROPE RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26Â Â EUROPE RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27Â Â EUROPE RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28  PORTER’S FIVE FORCE MODEL
FIGURE 29Â Â THE UNITED KINGDOM RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30Â Â FRANCE RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 31Â Â GERMANY RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 32Â Â SPAIN RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 33Â Â ITALY RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 34Â Â REST OF EUROPE RAT MODEL MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- REST OF EUROPE
- EUROPE
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
Choose License Type
RELATED REPORTS
-
EUROPE MOBILE IMAGING SERVICES MARKET FORECAST 2025-2032
-
EUROPE ATV AND UTV MARKET FORECAST 2025-2032
-
EUROPE GAMING MARKET FORECAST 2025-2032
-
EUROPE ORTHOGNATHIC CRANIOMAXILLOFACIAL (CMF) DEVICES MARKET FORECAST 2025-2032
-
GLOBAL HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
ASIA-PACIFIC HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
EUROPE HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
NORTH AMERICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
LATIN AMERICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032